Understanding Kidney Disease
Chronic kidney disease (CKD) is a progressive condition in which the kidneys gradually lose their ability to filter waste and excess fluid from the blood. Affecting over 800 million people globally, CKD can result from diabetes, high blood pressure, glomerulonephritis, or polycystic kidney disease.
As kidney function declines, waste products accumulate in the body, leading to complications including anemia, bone disease, cardiovascular problems, and eventual kidney failure requiring dialysis or transplantation. The condition is classified in five stages based on glomerular filtration rate (GFR).
Conventional treatment focuses on managing underlying causes and slowing progression through blood pressure control, dietary modifications, and medications. Regenerative medicine introduces the possibility of supporting kidney tissue repair and reducing the fibrosis that drives progressive kidney damage.
Common Symptoms
- Fatigue and weakness
- Swelling in legs, ankles, or feet (edema)
- Changes in urination frequency or volume
- Shortness of breath
- Nausea and appetite loss
- Persistent itching
- Elevated blood pressure
How MSC Therapy May Help
MSCs may support kidney health through their anti-fibrotic, anti-inflammatory, and regenerative properties. Kidney fibrosis, the scarring that replaces functional kidney tissue, is a primary driver of CKD progression. MSCs have shown the ability to reduce fibrotic activity by modulating the cells responsible for scar tissue formation.
The anti-inflammatory effects of MSCs are critical for kidney disease, as chronic inflammation accelerates tubular damage and glomerular injury. MSCs may help suppress inflammatory pathways, protect kidney tubular cells from further damage, and promote the survival of functional nephrons.
Additionally, MSCs release vascular endothelial growth factor (VEGF) and other angiogenic factors that support the repair of damaged blood vessels within the kidney. Healthy blood flow is essential for kidney filtration, and improved vascularization may support better overall renal function.
Our Treatment Approach
Renal Function Assessment
Comprehensive kidney evaluation including GFR, creatinine, BUN, proteinuria levels, and imaging to determine the stage and pattern of kidney damage.
IV MSC Infusion
Systemic intravenous delivery of MSCs targeting renal inflammation, fibrosis reduction, and support for remaining nephron function.
Anti-Fibrotic Support
Exosome co-therapy and complementary treatments designed to amplify the anti-fibrotic and regenerative effects of MSC therapy on kidney tissue.
Monitoring & Follow-up
Regular monitoring of kidney function markers, dietary guidance, and coordination with your nephrologist to track improvements and adjust care.